Cynthia Marie Butitta
Independent DirectorMs. Cynthia Marie Butitta, also known as Cindy, MBA serves as an Independent Director at Century Therapeutics, Inc. since February 2021. She serves as an Independent Director at Olema Oncology, Inc. (formerly known as Olema Pharmaceuticals, Inc.) since August 2020. She has been Non-Executive Director of Autolus Therapeutics Plc. since June 15, 2018. Ms. Butitta served as Director of Autolus Ltd from March 12, 2018 until June 6, 2018. Ms. Butitta serves as Independent Director of Urogen Pharma Ltd. since October 2017. She served as Chief Financial Officer of Kite Pharma Inc. from January 8, 2014 to May 2016 and as its Chief Operating Officer from March 2014 to September 2017. She also served as Executive Vice President at Kite Pharma from January 2014 to May 2016. Ms. Butitta is a seasoned financial and operational executive with leadership experience in both biotechnology and high-technology industries. Previously, she served as Senior Vice President and Chief Financial Officer of NextWave Pharmaceuticals, Inc. since May 2011 until December 2012. She served as Chief Operating Officer from March 2001 to December 22, 2010 and was its Chief Financial Officer of Telik Inc., from August 1998 to December 22, 2010 and Vice President of Finance and Administration and Chief Financial Officer of Connetics, Inc. Ms. Butitta also served as Principal Accounting Officer of Telik, Incorporated until December 2010. She has also held executive leadership roles at InSite Vision Inc. She received a B.S. degree with honors in Business and Accounting from Edgewood College in Madison, Wisconsin and an MBA in Finance from the University of Wisconsin-Madison. From May 2011 to December 2012, she was Senior Vice President and Chief Financial Officer at Next Wave Pharmaceuticals Inc., a specialty pharmaceutical company.
Positions
- Company NameUroGen Pharma Ltd.Stock CodeURGNPositionIndependent DirectorColleagues
- EAElizabeth A. BarrettPresident, CEO & Director
- ASArie S. BelldegrunIndependent Chairman
- JDJason Drew SmithGeneral Counsel, Chief Compliance Officer & Corporate Secretary
- MPMark P. SchoenbergChief Medical Officer
- CDChristopher DegnanChief Financial Officer
- VIVincent I. PerroneSenior Director of Investor Relations
- HLHerbert LeporChairman of Scientific Advisory Board
- LSLeana S. WenIndependent Director
- Company NameOlema Oncology, Inc.Stock CodeOLMAPositionIndependent DirectorColleagues
- SPSean P. BohenPresident, CEO & Director
- ITIan T. ClarkIndependent Chairperson of the Board
- SMShawnte M. MitchellChief Legal Officer & Corporate Secretary
- JOJason O’ByrneCFO, Principal Financial Officer & Accounting Officer
- DCDavid C. MylesChief Scientific Officer
- COCourtney O'KonekVice President of Corporate Communications
- FPFrank P. McCormickChairman of Scientific Advisory Board
- CMCynthia Marie ButittaIndependent Director
- SGScott GarlandIndependent Director
- Company NameAutolus Therapeutics plcStock CodeAUTLPositionIndependent Non-Executive DirectorColleagues
- CMChristian Martin ItinCEO & Director
- MWMichael Weston BonneyIndependent Chairman of the Board
- MPMartin PuleFounder, Senior VP & Chief Scientific Officer
- RFRobert F. DolskiSenior VP & CFO
- CVChristopher VannSenior VP & COO
- PMPatrick McIlvennySenior VP of Finance, Chief Accounting Officer & Principal Accounting Officer
- LCLinda Cathavina BainIndependent Non-Executive Director
- CMCynthia Marie ButittaIndependent Non-Executive Director
- WDWilliam Douglas YoungIndependent Non-Executive Director
